Any adverse events relating to Baxter products should be reported to Baxter’s Pharmacovigilance team using the following contact details:
Phone: +44 (0)1635 206360
Email: [email protected]
Ensuring patient safety is extremely important to us and we take the safety of all our medicines and devices very seriously.
Adverse Events may also be reported to the HPRA; Reporting forms and information can be found at https://www.hpra.ie/homepage/about-us/report-an-issue
Important safety links
Information on the correct use of Baxter fibrin sealants with spray application: www.baxterspraysafety.com
Information on the use of glucose monitors in patients using Extraneal: www.glucosesafety.com/cont-eu.html